SOURCE: ALR Technologies, Inc.

March 12, 2007 13:25 ET

PrecisionRx Technologies & Services Announces Medication Compliance Program for Canada

Signs Agreement to Provide ALR Technologies' Compliance Reminder Products to Pharmacies and Patients

WINSTON-SALEM, NC -- (MARKET WIRE) -- March 12, 2007 --ALR Technologies, Inc. (OTCBB: ALRT) announces that PrecisionRx Technologies & Services Inc. will begin providing ALR Technologies' medication compliance products to pharmacies and patients in Canada beginning in the second quarter of 2007. PrecisionRx Technologies & Services will be working in partnership with Gennium Pharmaceutique, a leading provider of generic medications and other services to pharmacies in Quebec.

PrecisionRx Technologies & Services, working with Gennium Pharmaceutique, will become the first provider of medications in Canada to offer this valuable service, according to Connie Casola, the Director of Professional Services for Gennium Pharmaceutique. "We are pleased to be working with ALR Technologies on this much needed service to people who are taking medications for chronic conditions. The ALR products bring an affordable and easy to use solution to the long known problem of patient noncompliance."

"Patient noncompliance brings about increasing health problems and escalating costs to our health care system," adds Casola. "We are pleased to be the first company to offer a program throughout Canada to help address this serious issue."

About Gennium Pharmaceutique and PrecisionRx Technologies & Services, Inc.

Gennium Pharmaceutique is a leading provider of generic medications to pharmacies and healthcare systems in Quebec, and is the exclusive distributor of Genpharm generic medication in the Province to retail pharmacies. Entirely Quebec owned and managed, Gennium Pharmaceutique prides itself on being a provider of value added services to complement medical healthcare regimes. With 100% dedication, the Gennium Pharmaceutique team is committed to exceed the needs and expectations of its partner pharmacists, while remaining on the cutting edge of both pharmaceutical innovation and professional service. To do so, Gennium Pharmaceutique depends on its exceptional sales representatives and its wide range of exclusive turnkey services. PrecisionRx Technologies & Services Inc. is a company that specializes in professional services to pharmacies and hospitals in Canada. For more information, please contact: conniec@genn.ca.

About ALR Technologies, Inc.

ALR Technologies, Inc. (ALRT) specializes in health and disease management products and services. ALRT designs and manufactures health management compliance products and monitoring and intervention systems to meet the needs of several targeted user groups. ALRT's system, branded Constant Health Companion™, responds to a serious gap in standard disease management practices in the US. It provides for continued compliance supervision to help keep people healthy, whether they are recovering from an organ transplant, suffer from diabetes, heart disease, asthma, COPD, or live with other serious conditions. More information on ALR Technologies and its products can be found at http://www.alrt.com. More information about the Constant Health Companion can be found at: http://www.alrt.com/products/alrt500.html.

This release contains certain "forward-looking statements" relating to ALR Technologies' business, and these statements reflect the current views of ALR Technologies with respect to future events and are subject to certain risks, uncertainties and assumptions. When used, the words "estimate," "expect," "anticipate," "believe" and similar expressions are intended to identify such forward-looking statements. There are many factors that could cause the actual results, performance or achievements of ALR Technologies and its products to be materially different from any future results, performances or achievements that may be expressed or implied by such forward-looking statements. Further management discussions of risks and uncertainties can be found in the company's quarterly filings with the Securities Exchange Commission.

Contact Information

  • Public and Investor Relations:
    Mercom Capital Group, llc
    tel: 1.512.828.6645
    e-mail: Email Contact